Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,259 signal articles · 37 in last 24h · 115,274 total before filter · latest 1h ago
37last 24h
1800last 7d
299● bullish (7d)
170● bearish (7d)
205publishers
AllMacro321Earnings849M&A104Regulatory25Product16Analyst25
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearishshow all (incl. clickbait)
DraftKings After Earnings: Buy, Hold, or Run?
24/7 Wall St.5d agobullish
DraftKings After Earnings: Buy, Hold, or Run?

DraftKings just posted its worst margin quarter in years while simultaneously launching a business growing five times faster than its core sportsbook ever did. One of those stories is going to dominate the next 90 days, and the NFL season will decide which.

Cigna Group (CI) Reports Q2 Earnings And Buybacks, Is It Trading At A Discount?
Simply Wall St.6d agobullish
Cigna Group (CI) Reports Q2 Earnings And Buybacks, Is It Trading At A Discount?

Q2 earnings and buybacks put Cigna Group in focus Cigna Group (CI) is back on investors’ radar after reporting its second quarter 2026 results, alongside an update on a long running share repurchase program dating back to 2018. See our latest analysis for Cigna Group. Cigna Group’s latest earnings and long running buyback program have come alongside mixed share price momentum. The stock is up 2.63% on the day and has a modest 1.21% share price return year to date, while the 5 year total...

Is Halozyme Therapeutics (HALO) Fairly Valued As Earnings Beat And Guidance Rise?
Simply Wall St.7d agobullish
Is Halozyme Therapeutics (HALO) Fairly Valued As Earnings Beat And Guidance Rise?

Halozyme earnings beat and guidance hike reshape the story Halozyme Therapeutics (HALO) just put fresh numbers on the table, reporting second quarter 2026 results, raising full year revenue guidance and updating progress on its share repurchase programs. For the quarter ended June 30, 2026, revenue was reported at US$481 million compared with US$325.72 million for the same period a year earlier. Net income for the quarter was US$229.91 million compared with US$165.16 million a year ago. Basic...

Atlassian earnings beat drives 30% stock surge
Proactive8d agobullish
Atlassian earnings beat drives 30% stock surge

Atlassian (NASDAQ:TEAM) shares jumped more than 30% on Friday after the software maker posted fourth-quarter revenue and cloud growth that topped analyst estimates and issued a stronger-than-expected cloud revenue outlook for fiscal 2027. Revenue for the quarter came in at $1.8 billion, up...

Howmet Stock Pops After Earnings But Remains Inside Buy Zone
Investor's Business Daily8d agobullish
Howmet Stock Pops After Earnings But Remains Inside Buy Zone

Howmet is the Big Cap 20 component in focus as the stock tests a key level after breaking out in June. The stock is wading in a 5% buy zone, rendering it actionable now. Both Howmet and fellow aerospace stock ATI reported robust earnings, causing several of these names to rally in unison.